Aileron Therapeutics, Inc.ALRNNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Trend
Above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
0.00%
↑ 100% above average
Average (39q)
-26.05%
Historical baseline
Range
High:783.33%
Low:-1900.00%
Volatility
-10302.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 100.00% |
| Q2 2024 | 93.22% |
| Q1 2024 | -171.95% |
| Q4 2023 | 783.33% |
| Q3 2023 | 0.00% |
| Q2 2023 | 72.09% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 100.00% |
| Q2 2022 | -2.44% |
| Q1 2022 | -2.50% |
| Q4 2021 | -2.56% |
| Q3 2021 | 2.50% |
| Q2 2021 | -1900.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | -5.25% |
| Q3 2019 | -3.97% |
| Q2 2019 | -3.11% |
| Q1 2019 | -5.38% |
| Q4 2018 | 8.33% |
| Q3 2018 | 18.78% |
| Q2 2018 | -9.78% |
| Q1 2018 | -12.41% |
| Q4 2017 | -12.71% |
| Q3 2017 | -21.01% |
| Q2 2017 | -7.44% |
| Q1 2017 | 4.85% |
| Q4 2016 | -18.69% |
| Q3 2016 | -24.88% |
| Q2 2016 | 16.33% |
| Q1 2016 | -23.35% |
| Q4 2015 | -13.80% |